I-MAB - American Depositary Shares (IMAB)

I-Mab is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative T-cell engagers and monoclonal antibodies for the treatment of cancer and autoimmune diseases

The company leverages its proprietary technology platform to create therapies that target specific biological pathways, aiming to address unmet medical needs in oncology. With a strong emphasis on research and collaboration, I-Mab works to bring advanced therapies to patients worldwide, enhancing treatment options and outcomes in the field of medicine.